HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

by Sonia Pernas, Sara M. Tolaney
Published 2019-03-01

Evidence to date: talazoparib in the treatment of breast cancer

by Exman P, Barroso-Sousa R, Tolaney SM
Published 2019-07-01

CDK4/6 inhibition in breast cancer: current practice and future directions

by Sonia Pernas, Sara M. Tolaney, Eric P. Winer, Shom Goel
Published 2018-07-01

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

by Luiza N. Weis, Sara M. Tolaney, Carlos H. Barrios, Romualdo Barroso-Sousa
Published 2021-09-01

Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia

by Lindsay L. Peterson, Maryam Lustberg, Sara M. Tolaney, Mikel Ross, Elahe Salehi, Steven J. Isakoff
Published 2020-06-01

The effects of releasing early results from ongoing clinical trials

by Steffen Ventz, Sergio Bacallado, Rifaquat Rahman, Sara Tolaney, Jonathan D. Schoenfeld, Brian M. Alexander, Lorenzo Trippa
Published 2021-02-01

Patients’ quality of life and side effect perceptions in monarchE, a study of abemaciclib plus endocrine therapy in adjuvant treatment of HR+, HER2-, node-positive, high-risk, earl...

by S. Tolaney, I. Blancas, Y.-H. Im, P. Rastogi, J. Brown, A. Shahir, A. Zimmermann, F. Boyle
Published 2021-04-01

Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review

by Cuyún Carter G, Mohanty M, Stenger K, Morato Guimaraes C, Singuru S, Basa P, Singh S, Tongbram V, Kuemmel S, Guarneri V, Tolaney SM
Published 2021-08-01

Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from t...

by Patrick Neven, Hope S. Rugo, Sara M. Tolaney, Hiroji Iwata, Masakazu Toi, Matthew P. Goetz, Peter A. Kaufman, Yi Lu, Nadine Haddad, Karla C. Hurt, George W. Sledge
Published 2021-08-01

Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer

by Laura M. Spring, Shealagh L. Clark, Tianyu Li, Shom Goel, Nabihah Tayob, Elene Viscosi, Elizabeth Abraham, Dejan Juric, Steven J. Isakoff, Erica Mayer, Beverly Moy, Jeffrey G. Supko, Sara M. Tolaney, Aditya Bardia
Published 2021-08-01

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study

by Romualdo Barroso-Sousa, Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo G. Pastorello, Edward T. Richardson III, Deborah Dillon, Zohreh Amoozgar, Beth Overmoyer, Stuart J. Schnitt, Eric P. Winer, Elizabeth A. Mittendorf, Eliezer Van Allen, Dan G. Duda, Sara M. Tolaney
Published 2021-08-01

Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer

by Zachary T. Weber, Katharine A. Collier, David Tallman, Juliet Forman, Sachet Shukla, Sarah Asad, Justin Rhoades, Samuel Freeman, Heather A. Parsons, Nicole O. Williams, Romualdo Barroso-Sousa, Elizabeth H. Stover, Haider Mahdi, Carrie Cibulskis, Niall J. Lennon, Gavin Ha, Viktor A. Adalsteinsson, Sara M. Tolaney, Daniel G. Stover
Published 2021-05-01

The Immunology of Hormone Receptor Positive Breast Cancer

by Jonathan Goldberg, Ricardo G. Pastorello, Ricardo G. Pastorello, Tuulia Vallius, Janae Davis, Janae Davis, Yvonne Xiaoyong Cui, Judith Agudo, Judith Agudo, Adrienne G. Waks, Tanya Keenan, Sandra S. McAllister, Sandra S. McAllister, Sandra S. McAllister, Sara M. Tolaney, Elizabeth A. Mittendorf, Elizabeth A. Mittendorf, Elizabeth A. Mittendorf, Elizabeth A. Mittendorf, Jennifer L. Guerriero, Jennifer L. Guerriero, Jennifer L. Guerriero, Jennifer L. Guerriero
Published 2021-05-01

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

by Tanya E. Keenan, Jennifer L. Guerriero, Romualdo Barroso-Sousa, Tianyu Li, Tess O’Meara, Anita Giobbie-Hurder, Nabihah Tayob, Jiani Hu, Mariano Severgnini, Judith Agudo, Ines Vaz-Luis, Leilani Anderson, Victoria Attaya, Jihye Park, Jake Conway, Meng Xiao He, Brendan Reardon, Erin Shannon, Gerburg Wulf, Laura M. Spring, Rinath Jeselsohn, Ian Krop, Nancy U. Lin, Ann Partridge, Eric P. Winer, Elizabeth A. Mittendorf, David Liu, Eliezer M. Van Allen, Sara M. Tolaney
Published 2021-09-01

Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx^® Digital Spatial Profiler

by Helga Bergholtz, Jodi M. Carter, Alessandra Cesano, Maggie Chon U Cheang, Sarah E. Church, Prajan Divakar, Christopher A. Fuhrman, Shom Goel, Jingjing Gong, Jennifer L. Guerriero, Margaret L. Hoang, E. Shelley Hwang, Hellen Kuasne, Jinho Lee, Yan Liang, Elizabeth A. Mittendorf, Jessica Perez, Aleix Prat, Lajos Pusztai, Jason W. Reeves, Yasser Riazalhosseini, Jennifer K. Richer, Özgür Sahin, Hiromi Sato, Ilana Schlam, Therese Sørlie, Daniel G. Stover, Sandra M. Swain, Alexander Swarbrick, E. Aubrey Thompson, Sara M. Tolaney, Sarah E. Warren, on behalf of the GeoMx Breast Cancer Consortium
Published 2021-09-01